Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thromboxane A2 receptor TPα is a G protein-coupled receptor encoded by the TBXA2R gene located on chromosome 19p13.3[1][5]. It is the α isoform resulting from alternative splicing of TBXA2R, differing from TPβ by a shorter cytoplasmic tail (343 vs. 407 amino acids)[1][5]. TPα is abundantly expressed in platelets, vascular smooth muscle, and endothelial cells, and is pivotal in hemostasis, platelet activation, and aggregation[1][3][5]. Upon activation by its primary ligand, thromboxane A2 (TXA2)—a short-lived eicosanoid produced by activated platelets—TPα initiates intracellular signaling via heterotrimeric G proteins (mainly Gq/G11), leading to platelet shape change, degranulation, aggregation, and vasoconstriction[1][3][5]. TPα is considered a prothrombotic receptor, with overactivity implicated in cardiovascular and cerebrovascular diseases, and its inhibition is a therapeutic strategy in cardiovascular disease[4][5]. Besides TXA2, TPα can also be activated by other eicosanoids (PGH2, PGF2α)[5]. Genetic and pharmacological studies in animal models demonstrate that TPα is essential for stable clot formation, and its blockade or deficiency results in impaired hemostasis and increased bleeding tendency[5]. In the vasculature, sustained TPα activation contributes to endothelial dysfunction, hypertension, and microvascular rarefaction[4]. TPα is thus a validated pharmacological target for antiplatelet and antithrombotic therapies, but its inhibition must be carefully balanced against bleeding risk.
Inhibition of TPα signaling reduces platelet activation, aggregation, and vasoconstriction; Antagonists competitively or non-competitively block receptor activation; Aspirin inhibits upstream TXA2 synthesis by irreversibly inhibiting cyclooxygenase-1 (COX-1)[2]; TPα primarily couples to Gq/G11, activating phospholipase C, increasing intracellular calcium, and inducing cell contraction; May also couple to G12/13 and Gs in some cell types[5][7].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thromboxane A2 receptor (TPα) (TPα).